Skip to main content

2024 SMFM Global Congress Main banner

Icon Legend

Presentation Icons

Foundation Awardee

Foundation Awardee

Poster Icons

Foundation Awardee

Foundation Awardee

Poster Sessions

Poster Session 1

(48) Effectiveness and safety of antenatal treatments for fetal and neonatal alloimmune thrombocytopenia (FNAIT)

Thursday, September 26, 2024

12:15 - 13:30 CET

Primary & Presenting Author(s)

Pamela Baker, PharmD (she/her/hers)

Director Clinical Scientist
Janssen Research & Development, LLC
Spring House, PA, United States

Coauthor(s)

PM

Paige Meizlik, MD

Janssen Research & Development, LLC
Spring House, Pennsylvania, United States
MT

May Lee Tjoa, PhD

Janssen Global Services, LLC
Cambridge, Massachusetts, United States